Fulgent Genetics Inc
NASDAQ:FLGT

Watchlist Manager
Fulgent Genetics Inc Logo
Fulgent Genetics Inc
NASDAQ:FLGT
Watchlist
Price: 17.87 USD 5.43% Market Closed
Market Cap: 541.5m USD
Have any thoughts about
Fulgent Genetics Inc?
Write Note

Intrinsic Value

The intrinsic value of one FLGT stock under the Base Case scenario is 14.58 USD. Compared to the current market price of 17.87 USD, Fulgent Genetics Inc is Overvalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

FLGT Intrinsic Value
14.58 USD
Overvaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Fulgent Genetics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for FLGT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about FLGT?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Fulgent Genetics Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Fulgent Genetics Inc

Provide an overview of the primary business activities
of Fulgent Genetics Inc.

What unique competitive advantages
does Fulgent Genetics Inc hold over its rivals?

What risks and challenges
does Fulgent Genetics Inc face in the near future?

Has there been any significant insider trading activity
in Fulgent Genetics Inc recently?

Summarize the latest earnings call
of Fulgent Genetics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Fulgent Genetics Inc.

Provide P/S
for Fulgent Genetics Inc.

Provide P/E
for Fulgent Genetics Inc.

Provide P/OCF
for Fulgent Genetics Inc.

Provide P/FCFE
for Fulgent Genetics Inc.

Provide P/B
for Fulgent Genetics Inc.

Provide EV/S
for Fulgent Genetics Inc.

Provide EV/GP
for Fulgent Genetics Inc.

Provide EV/EBITDA
for Fulgent Genetics Inc.

Provide EV/EBIT
for Fulgent Genetics Inc.

Provide EV/OCF
for Fulgent Genetics Inc.

Provide EV/FCFF
for Fulgent Genetics Inc.

Provide EV/IC
for Fulgent Genetics Inc.

Show me price targets
for Fulgent Genetics Inc made by professional analysts.

What are the Revenue projections
for Fulgent Genetics Inc?

How accurate were the past Revenue estimates
for Fulgent Genetics Inc?

What are the Net Income projections
for Fulgent Genetics Inc?

How accurate were the past Net Income estimates
for Fulgent Genetics Inc?

What are the EPS projections
for Fulgent Genetics Inc?

How accurate were the past EPS estimates
for Fulgent Genetics Inc?

What are the EBIT projections
for Fulgent Genetics Inc?

How accurate were the past EBIT estimates
for Fulgent Genetics Inc?

Compare the revenue forecasts
for Fulgent Genetics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Fulgent Genetics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Fulgent Genetics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Fulgent Genetics Inc compared to its peers.

Compare the P/E ratios
of Fulgent Genetics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Fulgent Genetics Inc with its peers.

Analyze the financial leverage
of Fulgent Genetics Inc compared to its main competitors.

Show all profitability ratios
for Fulgent Genetics Inc.

Provide ROE
for Fulgent Genetics Inc.

Provide ROA
for Fulgent Genetics Inc.

Provide ROIC
for Fulgent Genetics Inc.

Provide ROCE
for Fulgent Genetics Inc.

Provide Gross Margin
for Fulgent Genetics Inc.

Provide Operating Margin
for Fulgent Genetics Inc.

Provide Net Margin
for Fulgent Genetics Inc.

Provide FCF Margin
for Fulgent Genetics Inc.

Show all solvency ratios
for Fulgent Genetics Inc.

Provide D/E Ratio
for Fulgent Genetics Inc.

Provide D/A Ratio
for Fulgent Genetics Inc.

Provide Interest Coverage Ratio
for Fulgent Genetics Inc.

Provide Altman Z-Score Ratio
for Fulgent Genetics Inc.

Provide Quick Ratio
for Fulgent Genetics Inc.

Provide Current Ratio
for Fulgent Genetics Inc.

Provide Cash Ratio
for Fulgent Genetics Inc.

What is the historical Revenue growth
over the last 5 years for Fulgent Genetics Inc?

What is the historical Net Income growth
over the last 5 years for Fulgent Genetics Inc?

What is the current Free Cash Flow
of Fulgent Genetics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Fulgent Genetics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Fulgent Genetics Inc

Current Assets 326.5m
Cash & Short-Term Investments 213.1m
Receivables 64.9m
Other Current Assets 48.6m
Non-Current Assets 907.2m
Long-Term Investments 602.2m
PP&E 113.7m
Intangibles 159.2m
Other Non-Current Assets 32.1m
Current Liabilities 74m
Accounts Payable 19.8m
Accrued Liabilities 23.9m
Other Current Liabilities 30.3m
Non-Current Liabilities 21.3m
Long-Term Debt 448k
Other Non-Current Liabilities 20.9m
Efficiency

Earnings Waterfall
Fulgent Genetics Inc

Revenue
277.8m USD
Cost of Revenue
-177.2m USD
Gross Profit
100.6m USD
Operating Expenses
-189.3m USD
Operating Income
-88.7m USD
Other Expenses
-76.3m USD
Net Income
-165m USD

Free Cash Flow Analysis
Fulgent Genetics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

FLGT Profitability Score
Profitability Due Diligence

Fulgent Genetics Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Negative Free Cash Flow
Positive Gross Profit
Positive 3-Year Average ROIC
Positive 3-Year Average ROE
46/100
Profitability
Score

Fulgent Genetics Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

FLGT Solvency Score
Solvency Due Diligence

Fulgent Genetics Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Fulgent Genetics Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FLGT Price Targets Summary
Fulgent Genetics Inc

Wall Street analysts forecast FLGT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FLGT is 26.86 USD with a low forecast of 22.22 USD and a high forecast of 31.5 USD.

Lowest
Price Target
22.22 USD
24% Upside
Average
Price Target
26.86 USD
50% Upside
Highest
Price Target
31.5 USD
76% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for FLGT?

Click here to dive deeper.

Dividends

Fulgent Genetics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for FLGT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

FLGT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

FLGT News

Other Videos

Profile

Fulgent Genetics Inc Logo
Fulgent Genetics Inc

Country

United States of America

Industry

Health Care

Market Cap

545.7m USD

Dividend Yield

0%

Description

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. The company is headquartered in Temple City, California and currently employs 645 full-time employees. The company went IPO on 2016-09-28. The firm develops a technology platform, which offers a test menu. The company performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels. Its test offerings also include Solid Tumor Molecular Profiling for somatic cancer testing, Rapid Whole Genome testing developed for children in neonatal intensive care units or pediatric intensive care units its Newborn Genetic Analysis panel, and a single front-line test designed to comprehensively detect ataxia-related variants. The company also offers certain research service tests, which are ordered by research institutions and other similar institutional customers.

Contact

CALIFORNIA
Temple City
4978 Santa Anita Ave Ste 205
+16263500537.0
www.fulgentgenetics.com

IPO

2016-09-28

Employees

645

Officers

Chairman & CEO
Mr. Ming Hsieh
COO & President
Mr. Jian Xie
Chief Financial Officer
Mr. Paul Kim
Chief Scientific Officer & Laboratory Director
Dr. Hanlin Gao D.A.B.M.G., FACMG, M.D., Ph.D.
General Counsel & Chief Privacy Officer
Ms. Natalie Prescott
VP of Operations & Compliance and GM of Houston Office
Ms. Doreen Ng
Show More
Vice President of Business Development & Sales
Mr. Jakub Sram
Vice President of Human Resources
Ms. Ellen Tsui
Chief Commercial Officer
Mr. Brandon Perthuis
Chief Medical Officer
Dr. Lawrence M. Weiss M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one FLGT stock?

The intrinsic value of one FLGT stock under the Base Case scenario is 14.58 USD.

Is FLGT stock undervalued or overvalued?

Compared to the current market price of 17.87 USD, Fulgent Genetics Inc is Overvalued by 18%.

Back to Top